Helix Partner-02
/ BioCardia, University of Milan
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 02, 2019
BioCardia reports 2018 financial results and recent business highlights
(Businesswire)
- "BioCardia expanded its partnership with CellProThera to a clinical trial in Singapore which will evaluate Cell ProThera’s therapy delivered by BioCardia’s Helix™ Biotherapeutic Delivery System for the treatment of patients following a heart attack. The agreement offers the potential for BioCardia to receive double-digit royalty payments on future sales of the combination product."
Licensing / partnership
1 to 1
Of
1
Go to page
1